Adjunctive raloxifene enhances results in women with refractory schizophrenia Raloxifene hydrochloride, a selective estrogen receptor modulator with combined agonist and antagonist activity, minimized disease seriousness and increased possibility of clinical response in females with treatment-resistant schizophrenia, according to recent …